炎症性腸疾患を抱える高齢者におけるベドリズマブと腫瘍壊死因子拮抗薬の比較的な結果と安全性

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation1987 · 50,100 citations
2. 2Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients2021 · 27 citations
3. 3First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis2020 · 383 citations
4. 4The use of propensity score methods with survival or time‐to‐event outcomes: reporting measures of effect similar to those used in randomized experiments2013 · 1,444 citations
5. 5Assessment of the Diagnoses of Crohn's Disease and Ulcerative Colitis in a Danish Hospital Information System1996 · 247 citations